Sumitomo Mitsui Trust Group Inc. lessened its position in Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) by 75.0% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 387,708 shares of the real estate investment trust's stock after selling 1,164,401 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned approximately 0.11% of Healthcare Realty Trust worth $6,552,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Proficio Capital Partners LLC purchased a new position in Healthcare Realty Trust during the fourth quarter valued at $440,000. Smartleaf Asset Management LLC raised its stake in Healthcare Realty Trust by 59.0% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,650 shares of the real estate investment trust's stock valued at $27,000 after buying an additional 612 shares during the last quarter. Jones Financial Companies Lllp raised its stake in Healthcare Realty Trust by 68.7% during the fourth quarter. Jones Financial Companies Lllp now owns 3,067 shares of the real estate investment trust's stock valued at $52,000 after buying an additional 1,249 shares during the last quarter. Steward Partners Investment Advisory LLC raised its stake in Healthcare Realty Trust by 3,419.8% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 28,510 shares of the real estate investment trust's stock valued at $483,000 after buying an additional 27,700 shares during the last quarter. Finally, Synergy Investment Management LLC purchased a new position in Healthcare Realty Trust during the fourth quarter valued at $36,000.
Wall Street Analyst Weigh In
HR has been the subject of a number of research analyst reports. Wedbush reduced their target price on Healthcare Realty Trust from $18.00 to $16.00 and set a "neutral" rating for the company in a report on Monday, May 5th. JPMorgan Chase & Co. reduced their target price on Healthcare Realty Trust from $18.00 to $17.00 and set a "neutral" rating for the company in a report on Thursday, June 26th. Wall Street Zen lowered Healthcare Realty Trust from a "hold" rating to a "sell" rating in a report on Saturday, May 31st. Finally, Wells Fargo & Company reduced their target price on Healthcare Realty Trust from $16.00 to $15.00 and set an "underweight" rating for the company in a report on Monday, June 2nd. Two analysts have rated the stock with a sell rating and four have issued a hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $16.40.
Read Our Latest Report on HR
Healthcare Realty Trust Stock Down 0.8%
Shares of Healthcare Realty Trust stock traded down $0.13 on Friday, reaching $15.92. The company's stock had a trading volume of 2,346,574 shares, compared to its average volume of 3,150,402. The company has a market capitalization of $5.59 billion, a price-to-earnings ratio of -14.61 and a beta of 0.89. Healthcare Realty Trust Incorporated has a 52 week low of $14.09 and a 52 week high of $18.90. The firm's fifty day simple moving average is $15.03 and its two-hundred day simple moving average is $15.96.
Healthcare Realty Trust (NYSE:HR - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The real estate investment trust reported $0.39 EPS for the quarter, meeting analysts' consensus estimates of $0.39. The company had revenue of $288.86 million during the quarter, compared to analysts' expectations of $297.39 million. Healthcare Realty Trust had a negative return on equity of 7.06% and a negative net margin of 31.32%. Healthcare Realty Trust's revenue for the quarter was down 9.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.39 earnings per share. As a group, research analysts predict that Healthcare Realty Trust Incorporated will post 1.59 EPS for the current year.
Healthcare Realty Trust Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, May 23rd. Investors of record on Monday, May 12th were given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a yield of 7.79%. The ex-dividend date was Monday, May 12th. Healthcare Realty Trust's dividend payout ratio (DPR) is presently -113.76%.
Insider Buying and Selling
In other news, Director Thomas N. Bohjalian acquired 2,500 shares of Healthcare Realty Trust stock in a transaction that occurred on Tuesday, May 13th. The stock was bought at an average price of $14.71 per share, for a total transaction of $36,775.00. Following the completion of the transaction, the director owned 56,502 shares in the company, valued at $831,144.42. The trade was a 4.63% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.37% of the company's stock.
About Healthcare Realty Trust
(
Free Report)
Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.
Further Reading

Before you consider Healthcare Realty Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.
While Healthcare Realty Trust currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.